Latest News on VREX

Financial News Based On Company


Advertisement
Advertisement

About 77% of shares were represented as Varex Imaging (VREX) stockholders voted on the Teledyne merger.

https://www.stocktitan.net/sec-filings/VREX/8-k-varex-imaging-corp-reports-material-event-91f0b3fa4b26.html
Varex Imaging Corporation stockholders have approved the merger agreement with Teledyne Technologies Incorporated, with approximately 77% of outstanding shares represented at the special meeting. While the merger and an advisory compensation proposal passed, the completion of the acquisition remains subject to various conditions, including regulatory approvals and the absence of a Company Material Adverse Effect. Final voting results will be disclosed in an upcoming amendment to the Form 8-K.

Varex Imaging Corporation (VREX) Seasonal returns chart

https://au.finance.yahoo.com/quote/VREX/seasonality/
This article from Yahoo Finance presents the seasonal returns chart for Varex Imaging Corporation (VREX). It displays the average monthly price return for the company's stock from 2017 to 2026. The current stock price and recent performance data are also provided.

Varex Imaging Corporation (VREX) Seasonal returns chart

https://uk.finance.yahoo.com/quote/VREX/seasonality/
This article provides a seasonal returns chart for Varex Imaging Corporation (VREX), displaying average monthly price returns from 2017 to 2026. As of October 30, the stock price was 18.43 USD, showing a slight decrease of 0.05% at market close. The chart allows users to view historical seasonality over different timeframes.

32.4M votes back a merger that would make Varex Imaging (VREX) a wholly owned subsidiary.

https://www.stocktitan.net/sec-filings/VREX/8-k-a-varex-imaging-corp-amends-material-event-report-c340adbabb22.html
Varex Imaging Corporation (VREX) stockholders have approved the merger agreement with Teledyne Technologies Incorporated, with 32,426,328 votes in favor. This approval means Varex will become a wholly owned subsidiary of Teledyne, pending regulatory clearances, waiting-period expirations, and other contractual conditions. The compensation proposal for named executive officers was also approved.

Form 8K Varex Imaging Corp For: 29 October By Investing.com

https://za.investing.com/news/stock-market-news/form-8k-varex-imaging-corp-for-29-october-93CH-4535887
This article from Investing.com announces the filing of a Form 8K by Varex Imaging Corp, dated October 29. The brief report highlights the company's stock symbol (VREX) and its current performance (-0.05%). The primary content is the announcement of the SEC filing.
Advertisement

Form 8K Varex Imaging Corp For: 29 October By Investing.com

https://ca.investing.com/news/stock-market-news/form-8k-varex-imaging-corp-for-29-october-93CH-4914220
This article from Investing.com announces that Varex Imaging Corp. filed a Form 8K for October 29th. The Form 8K is a crucial SEC filing that companies use to announce significant events that shareholders should know about. The article itself is very brief and primarily serves as an alert for this filing.

Form 8K Varex Imaging Corp For: 22 October By Investing.com

https://ng.investing.com/news/stock-market-news/form-8k-varex-imaging-corp-for-22-october-93CH-2750745
Investing.com reported on a Form 8K filing by Varex Imaging Corp (VREX) for October 22. The article provides the title of the filing and its publication date. This brief news item confirms the existence of the SEC filing for the specified date.

Form 8K Varex Imaging Corp For: 22 October By Investing.com

https://za.investing.com/news/stock-market-news/form-8k-varex-imaging-corp-for-22-october-93CH-4518876
This article announces that Varex Imaging Corp (VREX) filed a Form 8K on October 22, 2026. The filing contains important information for investors regarding the company's recent activities or changes, which are typically disclosed in an 8K report. The brief notice encourages readers to view the details of the filing.

Form 8K Varex Imaging Corp For: 22 October By Investing.com

https://uk.investing.com/news/stock-market-news/form-8k-varex-imaging-corp-for-22-october-93CH-4924836
This article from Investing.com reports on Varex Imaging Corp's Form 8K filing for October 22, 2026. The brief announcement indicates the release of a regulatory document for the company, which is identified by its stock symbol VREX. No specific details about the content of the Form 8K are provided within the article.

Varex Imaging Updates Merger Proxy Amid Lawsuits; Regulatory Reviews Remain Pending

https://www.tradingview.com/news/tradingview:32ae6ede23325:0-varex-imaging-updates-merger-proxy-amid-lawsuits-regulatory-reviews-remain-pending/
Varex Imaging has supplemented its merger proxy disclosures following shareholder litigation and demand letters, though it continues to recommend approving the Teledyne merger. The company denies the claims of proxy disclosure deficiencies, stating that the supplemental information does not alter the merger consideration or the special meeting schedule. Regulatory reviews, including the HSR waiting period and NSIA review, are still pending, alongside antitrust clearances in several other countries.
Advertisement

Two grants of 5,411 stock units each go to Varex Imaging (VREX) legal chief Matthew Aaron Martinez.

https://www.stocktitan.net/sec-filings/VREX/form-4-varex-imaging-corp-insider-trading-activity-477cd7799ed9.html
Varex Imaging's Chief Legal Officer, Matthew Aaron Martinez, received two direct awards of 5,411 restricted stock units (RSUs) on October 12, 2026. These RSUs have different vesting schedules: a four-year award vesting 50% on August 15, 2028, and 50% on August 15, 2030, and a three-year cliff award vesting on August 15, 2029. The terms include provisions for pro-rata vesting and cash conversion at $18.90 per share, or forfeiture, if Varex's acquisition by Teledyne Technologies is consummated.

The Technical Signals Behind (VREX) That Institutions Follow

https://news.stocktradersdaily.com/news_release/8/The_Technical_Signals_Behind_VREX_That_Institutions_Follow_101426094402_1792028642.html
This article provides a technical analysis of Varex Imaging Corporation (NASDAQ: VREX), detailing key findings such as neutral near and mid-term readings but a positive long-term bias. It outlines institutional trading strategies including position, momentum breakout, and risk hedging, along with multi-timeframe signal analysis and AI-generated signals for support and resistance levels.

Form 4 Varex Imaging Corp: Matthew Aaron Martinez (CLO) For: 12 October

https://in.investing.com/news/stock-market-news/form-4-varex-imaging-corp-matthew-aaron-martinez-clo-for-12-october-93CH-5633876
This article reports on a Form 4 filing for Varex Imaging Corp, detailing a transaction by Matthew Aaron Martinez, the Chief Legal Officer (CLO), on October 12. The filing indicates insider activity for the company, specifically involving a key executive.

Form 4 Varex Imaging Corp: Matthew Aaron Martinez (CLO) For: 12 October

https://uk.investing.com/news/stock-market-news/form-4-varex-imaging-corp-matthew-aaron-martinez-clo-for-12-october-93CH-4910958
The article reports on a Form 4 filing for Varex Imaging Corp, specifically detailing a transaction by Matthew Aaron Martinez (CLO) on October 12. It reiterates the headline information without providing further details about the nature of the transaction. The piece also includes financial market data and popular articles from Investing.com.

Form 4 Varex Imaging Corp: Matthew Aaron Martinez (CLO) For: 12 October

https://ng.investing.com/news/stock-market-news/form-4-varex-imaging-corp-matthew-aaron-martinez-clo-for-12-october-93CH-2737054
This article reports on a Form 4 filing for Varex Imaging Corp, detailing a transaction involving Matthew Aaron Martinez, the company's CLO, on October 12. The filing is a standard regulatory disclosure for insider trading activity.
Advertisement

Form 4 Varex Imaging Corp For: Oct 12 Filed by: Martinez Matthew Aaron

https://www.streetinsider.com/SEC+Filings/Form+4+Varex+Imaging+Corp+For%3A+Oct+12+Filed+by%3A+Martinez+Matthew+Aaron/27188044.html
Matthew Aaron Martinez, Chief Legal Officer of Varex Imaging Corp (VREX), filed a Form 4 detailing derivative securities transactions on October 12, 2026. The filing indicates the acquisition of 5,411 restricted stock units (RSUs) in two tranches, with specific vesting schedules over three and four years. The filing also outlines accelerated vesting and cash conversion terms for these RSUs in the event of an acquisition of Varex Imaging Corp by Teledyne Technologies Incorporated.

No voting power or shares remain reported by Allspring in Varex Imaging (VREX).

https://www.stocktitan.net/sec-filings/VREX/schedule-13g-a-varex-imaging-corp-amended-passive-investment-disclosu-e110632053e3.html
Allspring Global Investments Holdings, LLC has filed an amended Schedule 13G, reporting that it no longer holds any beneficial ownership in Varex Imaging Corp (VREX). The filing indicates that Allspring now owns 0 shares, representing 0.0% of the class, and holds zero sole and shared voting and dispositive power over Varex common stock. This filing signifies a complete divestment of their previous stake in the company.

An investor reports a Varex Imaging (VREX) stake with voting power over 1.02M shares.

https://www.stocktitan.net/sec-filings/VREX/schedule-13g-a-varex-imaging-corp-amended-passive-investment-disclosu-c310eb50e0eb.html
Pzena Investment Management, LLC has reported a 4.2% passive stake in Varex Imaging Corp (VREX) through an SEC SCHEDULE 13G/A filing. The firm's clients beneficially own 1,785,166 shares, with Pzena holding sole voting power over 1,020,770 shares and sole dispositive power over 1,785,166 shares. This filing indicates that clients retain dividend and sale proceeds rights, with no single client holding more than 5% interest in the class.

Lobbying Update: $30,000 of VAREX IMAGING CORPORATION lobbying was just disclosed

https://www.quiverquant.com/news/Lobbying+Update%3A+%2430%2C000+of+VAREX+IMAGING+CORPORATION+lobbying+was+just+disclosed
Varex Imaging Corporation (VREX) disclosed $30,000 in lobbying expenses for Q3 2026, primarily focused on the "Promotion of high energy X-ray systems for CBP Non-intrusive inspection." The article also details recent insider trading activity, showing two sales by officers totaling over $2.5 million, and significant hedge fund activity with both additions and removals of VREX shares in Q2 2026.

VREXV5053657 Bond Profile: Coupon and Redemption

https://www.tradingview.com/symbols/FINRA-VREXV5053657/profile/
This article provides a detailed profile of the VREXV5053657 bond issued by Varex Imaging Corporation. It covers key information such as the issuer's details, issue and maturity dates, face value, coupon rate, and payment schedule. The bond has a fixed rate of 7.88% with semi-annual payments and matures on October 15, 2027.
Advertisement

Varex Imaging Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Varex Imaging Corporation - VREX

https://www.marketscreener.com/news/varex-imaging-investor-alert-kahn-swick-foti-llc-investigates-adequacy-of-price-and-process-in-p-ce785adfd88df226
Kahn Swick & Foti, LLC (KSF) is investigating the proposed sale of Varex Imaging Corporation (NasdaqGS: VREX) to Teledyne Technologies Incorporated (NYSE: TDY) for $18.90 per share in cash. KSF aims to determine if this consideration adequately values Varex Imaging and if the process leading to the sale was fair. Shareholders who believe the offer undervalues the company are encouraged to contact KSF to discuss their legal rights.

Varex Imaging (NASDAQ: VREX) director trims stake, now holds 15,329 shares

https://www.stocktitan.net/sec-filings/VREX/form-4-varex-imaging-corp-insider-trading-activity-fe8fa46fbab0.html
Varex Imaging Corp (VREX) director Jay K. Kunkel sold 8,121 shares of common stock on September 14, 2026, at $18.48 per share. Following this transaction, Kunkel directly holds 15,329 shares. The sale was an open-market or private transaction and was not conducted under a Rule 10b5-1 trading plan.

Insider Move: Shubham Maheshwari Exercises Options, Realizing $783K At Varex Imaging

https://www.benzinga.com/news/26/09/61818884/insider-move-shubham-maheshwari-exercises-options-realizing-783k-varex-imaging
Shubham Maheshwari, CFO at Varex Imaging (NASDAQ: VREX), exercised stock options for 160,944 shares worth $783,797, according to a recent SEC filing. The article highlights Varex Imaging's financial health, including its revenue growth, profitability, debt management, and valuation metrics. It also explains the significance of insider transactions for investors.

VREX: Varex Imaging Corp Latest Stock Price, Analysis, News and Trading Ideas

https://stocktwits.com/symbol/VREX
This page provides the latest stock price, analysis, news, and trading ideas for Varex Imaging Corp (VREX). As of the article's time, VREX closed at $18.47 with a slight daily increase of 0.11%. The platform also indicates a bearish sentiment among users.

Varex Imaging director Kunkel sells $150k in shares

https://www.investing.com/news/insider-trading-news/varex-imaging-director-kunkel-sells-150k-in-shares-93CH-4902730?ampMode=1
Jay K. Kunkel, a director at Varex Imaging Corp (NASDAQ:VREX), sold 8,121 shares of the company's common stock for a total of $150,076 on September 14, 2026. Following this transaction, Kunkel beneficially owns 15,329 shares. The sale occurred while VREX trades near its 52-week high after a 61% gain over the past year, with InvestingPro analysis indicating the stock is currently overvalued.
Advertisement

Varex Imaging Director Jay K. Kunkel Sells 8,121 Shares at $18.48 Each

https://kalkinemedia.com/us/news/announcements/varex-imaging-director-jay-k-kunkel-sells-8121-shares-at-1848-each
Varex Imaging Corp Director Jay K. Kunkel sold 8,121 shares of the company's common stock at $18.48 per share on September 14, 2026. This transaction was reported in a Form 4 filing with the SEC on September 15, 2026. Following the sale, Kunkel retains direct ownership of 15,329 shares of Varex Imaging.

Varex Imaging CFO sells $2.4m in stock after option exercise

https://m.investing.com/news/insider-trading-news/varex-imaging-cfo-sells-24m-in-stock-after-option-exercise-93CH-4902731?ampMode=1
Shubham Maheshwari, CFO of Varex Imaging Corp, sold 130,000 shares for approximately $2.4 million after exercising stock options. This "sell-to-cover" transaction occurred as the stock traded near its 52-week high following a significant surge, despite InvestingPro's analysis suggesting it is slightly overvalued. Following these transactions, Maheshwari directly holds 139,972 shares.

Director at Varex Imaging (NASDAQ: VREX) plans $150K stock sale

https://www.stocktitan.net/sec-filings/VREX/144-varex-imaging-corp-sec-filing-bcc312778829.html
Varex Imaging Corp (VREX) director Jay K. Kunkel has filed a Form 144 notice indicating his intent to sell 8,121 shares of common stock, valued at approximately $150,076.08, on NASDAQ. These shares stem from restricted stock vesting events in February 2024 and February 2025. The sale will be executed through Fidelity Brokerage Services LLC.

Varex Imaging (NASDAQ: VREX) filer plans $2.4M stock sale

https://www.stocktitan.net/sec-filings/VREX/144-varex-imaging-corp-sec-filing-d68b6da6d85e.html
A recent SEC Form 144 filing indicates that Shubham Maheshwari, a holder of Varex Imaging (VREX), plans to sell 130,000 common shares through Fidelity Brokerage Services LLC. The sale, valued at approximately $2.4 million, is tied to a stock option exercise with an expected transaction date of September 11, 2026. This notice provides transparency regarding potential insider activity and the upcoming entry of these shares into the market.

Why Is Varex Imaging Stock Soaring Monday? - Teledyne Technologies (NYSE:TDY), Varex Imaging (NASDAQ:VREX

https://www.benzinga.com/m-a/26/08/61077425/teledyne-snaps-up-varex-imaging-for-1-1-billion
Varex Imaging (NASDAQ: VREX) shares surged over 48% after Teledyne Technologies Inc. (NYSE: TDY) announced its agreement to acquire Varex for $1.1 billion in an all-cash transaction. This acquisition aims to expand Teledyne's presence in medical and industrial X-ray imaging, complementing their existing product portfolios. The deal, which has been unanimously approved by both boards, is expected to close in early 2027 and follows Varex's recent strong quarterly earnings report.
Advertisement

Varex Imaging Corp (VI4.SG) Stock Price, News, Quote & History

https://ca.finance.yahoo.com/quote/VI4.SG/dividends/
This article provides the stock price, news, quote, and history for Varex Imaging Corp (VI4.SG) on Yahoo Finance. It displays current market data, including the stock price and daily change, and offers links to various financial analysis tools like income statements, balance sheets, and dividend information.

Should Value Investors Buy VAREX IMAGING (VREX) Stock?

https://ca.finance.yahoo.com/news/value-investors-buy-varex-imaging-134003711.html
Zacks Investment Research recommends VAREX IMAGING (VREX) as a strong value stock due to its favorable Zacks Rank #2 (Buy) and "A" grade for Value. The article highlights VREX's attractive valuation metrics, including a P/E ratio of 12.78, a P/B ratio of 1.08, and a P/S ratio of 0.9, all of which are lower than its industry averages. These indicators suggest that VREX is currently undervalued and possesses a strong earnings outlook.

Pzena Investment Management LLC Invests $45.31 Million in Varex Imaging $VREX

https://www.marketbeat.com/instant-alerts/filing-pzena-investment-management-llc-invests-4531-million-in-varex-imaging-vrex-2026-08-18/
Pzena Investment Management LLC has acquired a new stake of 4.34 million shares in Varex Imaging (NASDAQ:VREX), valued at approximately $45.31 million, making it a 10.32% owner of the company. Despite Varex beating earnings per share estimates, its revenue fell short, and analysts currently have a cautious "Reduce" rating with a target price below its current trading price. Several other institutional investors also adjusted their holdings in Varex Imaging during recent quarters.

Varex Imaging (NASDAQ: VREX) outlines RSU vesting and tax-share withholding for HR chief

https://www.stocktitan.net/sec-filings/VREX/form-4-varex-imaging-corp-insider-trading-activity-01345a9189bb.html
Varex Imaging Corp's Chief Human Resources Officer, Karen L. Aranki, had 3,974 Restricted Stock Units (RSUs) vest on August 14, 2026. From these, 1,145 shares were withheld at $18.49 per share to cover tax obligations. Aranki now holds 3,975 remaining RSUs, with future vesting dates in 2026 and 2028.

Varex Imaging Corporation News | VREX Real-time News & Related Reports

https://finance.biggo.com/quote/VREX/news
This article provides an overview of Varex Imaging Corporation (VREX), including its current stock price, market capitalization, P/E ratio, and recent trading activity. It also lists various financial data points and indicates that the news and data are for reference only, not investment advice.
Advertisement

Rice Hall James & Associates LLC Purchases New Position in Varex Imaging $VREX

https://www.marketbeat.com/instant-alerts/filing-rice-hall-james-associates-llc-purchases-new-position-in-varex-imaging-vrex-2026-08-18/
Rice Hall James & Associates LLC has acquired a new position in Varex Imaging (NASDAQ:VREX), purchasing 1.45 million shares valued at approximately $15.1 million, representing a 3.43% stake. Despite this acquisition and Varex Imaging exceeding quarterly EPS estimates, analyst sentiment remains cautious with a "Reduce" consensus rating and a target price of $16.88. Several other institutional investors also adjusted their holdings in the company during recent quarters.

Varex Imaging (NASDAQ:VREX) Receives Consensus Recommendation of "Reduce" from Brokerages

https://www.marketbeat.com/instant-alerts/varex-imaging-nasdaqvrex-receives-consensus-recommendation-of-reduce-from-brokerages-2026-08-18/
Varex Imaging (NASDAQ:VREX) has received a consensus "Reduce" rating from seven brokerages, with one sell rating and six hold ratings, and an average 12-month price target of $16.875. This comes despite recent positive institutional activity and quarterly earnings that beat consensus estimates, though revenue fell short. Several firms, including Zacks Research and Oppenheimer, have recently downgraded their ratings on the stock.

Varex Imaging (NASDAQ:VREX) Stock Rating Lowered by CJS Securities

https://www.marketbeat.com/instant-alerts/varex-imaging-nasdaqvrex-stock-rating-lowered-by-cjs-securities-2026-08-17/
CJS Securities downgraded Varex Imaging (NASDAQ:VREX) from an "outperform" to a "market perform" rating. This downgrade aligns with other analysts who have issued "hold" or "sell" ratings, resulting in an average "Reduce" rating and a $16.88 consensus price target for the stock. Despite exceeding Q3 EPS estimates with $0.31, revenue of $210.5 million missed the $215.5 million consensus, and the company projects full-year EPS of $0.93.

Teledyne to Acquire Varex Imaging Corporation

https://www.azom.com/news.aspx?newsID=65706
Teledyne Technologies Incorporated announced its definitive agreement to acquire Varex Imaging Corporation for approximately $1.1 billion, or $18.90 per share in cash. Varex specializes in X-ray sources and digital X-ray detectors for various applications, complementing Teledyne's existing healthcare market presence with minimal product overlap. The acquisition is expected to close in early 2027, subject to regulatory and stockholder approvals.

Assenagon Asset Management S.A. Sells 372,475 Shares of Varex Imaging $VREX

https://www.marketbeat.com/instant-alerts/filing-assenagon-asset-management-sa-sells-372475-shares-of-varex-imaging-vrex-2026-08-16/
Assenagon Asset Management S.A. significantly reduced its stake in Varex Imaging (NASDAQ:VREX) by 80.6% in the second quarter, selling 372,475 shares and retaining 89,412 shares valued at $933,000. This move contrasts with other institutional investors like LSV Asset Management, Millennium Management, and Qube Research & Technologies, which increased their positions. Despite Varex Imaging beating EPS expectations, the stock holds a consensus "Reduce" rating and an average price target of $16.88 from analysts, indicating mixed sentiment and cautious outlook.
Advertisement

VAREX IMAGING (VREX) Q3 Earnings Beat Estimates

https://finance.yahoo.com/markets/stocks/articles/varex-imaging-vrex-q3-earnings-121505093.html
VAREX IMAGING (VREX) reported Q3 earnings of $0.31 per share, surpassing the Zacks Consensus Estimate of $0.22 per share, and revenues of $210.5 million, which missed the estimate. Despite the earnings beat, the company's shares have underperformed the S&P 500 year-to-date. The stock currently holds a Zacks Rank #3 (Hold) based on mixed estimate revisions.

Varex Imaging Corporation Stock 12‑Month Price Target Cut to $17.58, Implies 42% Upside

https://www.tradingview.com/news/tradingview:c5295e7a2f990:0-varex-imaging-corporation-stock-12-month-price-target-cut-to-17-58-implies-42-upside/
The average 12-month price target for Varex Imaging Corporation (VREX) stock has been lowered from $18 to $17.58 by 5 analysts, with individual forecasts ranging from $12 to $20 per share. This new target suggests a potential upside of approximately 42% from its August 7 closing price. The consensus rating among the 5 covering analysts remains "Buy," comprising 2 Buys and 3 Holds.

Teledyne to Acquire Varex Imaging for $1.1 Billion in Cash, Adding Oncology X-Ray Tech

https://finance.biggo.com/news/b92547cf-6e46-49b5-a7fe-184bc5441b0e
Teledyne Technologies announced its acquisition of Varex Imaging for $1.1 billion in an all-cash deal, paying $18.90 per share, a premium of over 50%. This strategic move expands Teledyne's X-ray portfolio by adding oncology-grade detectors and advanced photon-counting technology. The transaction, unanimously approved by both boards, is expected to close in early 2027, subject to regulatory and shareholder approvals.

Varex Imaging Agrees to Teledyne All-Cash Acquisition

https://www.tipranks.com/news/company-announcements/varex-imaging-agrees-to-teledyne-all-cash-acquisition
Varex Imaging has agreed to be acquired by Teledyne Technologies in an all-cash deal valued at approximately $1.1 billion. The acquisition, pending shareholder and regulatory approvals, will result in Varex becoming a wholly-owned subsidiary of Teledyne and its delisting from Nasdaq in early 2027. This merger aims to strengthen Teledyne's position in medical imaging and industrial inspection by integrating Varex's X-ray tubes and photon-counting detectors with Teledyne's existing portfolio.

Teledyne to acquire Varex in $1.1 billion deal

https://www.medicaldesignandoutsourcing.com/teledyne-to-acquire-varex-in-1-1-billion-deal/
Teledyne Technologies (NYSE: TDY) has announced its intent to acquire Varex Imaging Corporation (NASDAQ: VREX) for approximately $1.1 billion in cash, paying $18.90 per share. This acquisition will expand Teledyne's healthcare market presence with Varex's complementary X-ray sources and digital detectors, which are used in medical diagnostic imaging, security, and industrial applications. The transaction, unanimously approved by both boards, is expected to close in early 2027, pending regulatory and Varex stockholder approvals.
Advertisement

Teledyne inks $1.1B takeover of Varex Imaging

https://finance.yahoo.com/healthcare/articles/teledyne-inks-1-1b-takeover-100000428.html
Teledyne Technologies announced its acquisition of Varex Imaging for approximately $1.1 billion. This strategic move aims to expand Teledyne's presence in the healthcare market by integrating Varex's X-ray imaging components and products, which are complementary to Teledyne's existing digital imaging portfolio with minimal overlap. The deal, which requires regulatory approval, is expected to close early next year, further contributing to the high M&A activity in the medtech sector.

Teledyne to acquire Varex Imaging in $1.1B deal

https://radiologybusiness.com/topics/healthcare-management/mergers-and-acquisitions/teledyne-acquire-varex-imaging-11b-deal
Teledyne Technologies is set to acquire Varex Imaging for approximately $1.1 billion, integrating Varex's X-ray tubes and digital detectors into Teledyne's medical imaging portfolio. This strategic move aims to complement Teledyne's existing imaging technologies, particularly in areas like high-radiation environments and advanced photon-counting detectors. The transaction, unanimously approved by both boards, is expected to close in early 2027, pending regulatory and shareholder approvals, though some investors are reportedly considering litigation over the sale price.

Teledyne to acquire Varex Imaging in $1.1 billion deal

https://www.dotmed.com/news/story/66667
Teledyne Technologies announced its agreement to acquire Varex Imaging Corporation for approximately $1.1 billion. This acquisition will significantly expand Teledyne's medical and industrial X-ray imaging portfolio by adding Varex's X-ray tubes, digital X-ray detectors, and advanced photon-counting detectors. The deal, representing an 88% premium over Varex's stock price in late May 2026, is expected to close in early 2027, pending regulatory and shareholder approvals.

Varex Imaging downgraded to Neutral from Buy at B. Riley

https://www.tipranks.com/news/the-fly/varex-imaging-downgraded-to-neutral-from-buy-at-b-riley-thefly-news
B. Riley downgraded Varex Imaging (VREX) to Neutral from Buy, increasing the price target slightly to $18.90 from $18.00. This change comes after Varex Imaging agreed to be acquired by Teledyne Technologies for $18.90 per share in cash, leaving limited upside potential without a competing offer.

Teledyne to acquire Varex Imaging (VREX) in $1.1B all‑cash merger deal

https://www.stocktitan.net/sec-filings/VREX/8-k-varex-imaging-corp-reports-material-event-5ec75cb2f3bf.html
Teledyne Technologies will acquire Varex Imaging (VREX) in an all-cash merger deal valued at approximately $1.1 billion, including equity awards and net debt. Varex shareholders will receive $18.90 per share, and the transaction is expected to close in early 2027, subject to regulatory and stockholder approvals. The acquisition aims to complement Teledyne's existing healthcare and industrial imaging portfolio without significant product overlap.
Advertisement
Advertisement
Advertisement
Advertisement

Sign Up free to view live trades and discussion forum to make more informed financial decisions. No credit card is required for sign up!
View Daily Trades
Join Discussion

Advertisement
Advertisement
Advertisement
Advertisement